ABQ2015
Full time employment: Posting here.
Obtaining COVID therapeutics is getting tricky in my area. Our New Mexico Dept of Health (NMDOH) has a weekly press conference on the COVID status that I like to watch or afterwards review the posted slides. Before Christmas, the predominant COVID variant in my flyover state was delta but we are fast transitioning to omicron. Currently the NMDOH estimates omicron as 50-60% of our new cases and expects it to be 100% in a week or two.
Sotrovimab and Remdesivir infusions and the Paxlovid pill are the only effective treatments available in my state for omicron. Remdesivir requires three infusions over three days so uses more medical staff resources and the other two treatments are in short supply. Molnupiravir was listed on the NMDOH slides as just 30% effective. Currently NM is limiting distribution of Paxlovid to rural counties that are not close to infusion centers. So the NMDOH thinks it will be difficult to obtain therapeutics for omicron in the next two weeks until we can get more supplies.
They also stressed during the press conference that if your rapid test is positive, there is no need for a PCR test before seeking treatment although the medical center may perform their own PCR test.
Sotrovimab and Remdesivir infusions and the Paxlovid pill are the only effective treatments available in my state for omicron. Remdesivir requires three infusions over three days so uses more medical staff resources and the other two treatments are in short supply. Molnupiravir was listed on the NMDOH slides as just 30% effective. Currently NM is limiting distribution of Paxlovid to rural counties that are not close to infusion centers. So the NMDOH thinks it will be difficult to obtain therapeutics for omicron in the next two weeks until we can get more supplies.
They also stressed during the press conference that if your rapid test is positive, there is no need for a PCR test before seeking treatment although the medical center may perform their own PCR test.